New york city: Pioneering medical technology company, Xenco Medical has been crowned Medical Device/Diagnostics Company of the Year at the 2025 PM360 Trailblazer Awards held at Gotham Hall, New York City, on Sept 30.

According to BERNAMA News Agency, Xenco Medical earned the top honour in its category for its advancement in biomimetic implants, regenerative biomaterials, and composite polymer surgical instruments integrated with artificial intelligence (AI)-driven software technologies.

Xenco Medical founder and chief executive officer (CEO), Jason Haider said the company was honoured to receive the recognition and would continue to translate the promise of science into transformative outcomes for patients.

Meanwhile, PM360 CEO and publisher, Anna Stashower said this year’s winners showcase exactly what sets the industry apart-bold ideas, breakthrough innovation, and real-world impact.

Xenco Medical’s TrabeculeX Continuum technology, inspired by the principles of mechanotransduction, integrates regenerative biomaterials with AI-powered post-surgical rehabilitation.

Through its AI-driven pose assessment, the technology enables surgeons to remotely monitor pain scores, rehabilitation adherence and motion recovery, supporting the company’s mission to bridge gaps in surgical care.

Recognised for its value-based approach to healthcare, Xenco Medical’s single-use surgical implant systems streamline operations and reduce surgical turnover times by eliminating the need for sterilisation between procedures.

Earlier this year, Fast Company magazine named Xenco Medical among the World’s Most Innovative Companies for the second time.

Other winners at the ceremony included Merck and Company, named Pharmaceutical/Biotech Company of the Year, and Vertex Pharmaceuticals, which took the Specialty Pharma/Biotech Company of the Year title.